Literature DB >> 10666230

The IVS4 + 4 A to T mutation of the fanconi anemia gene FANCC is not associated with a severe phenotype in Japanese patients.

M Futaki1, T Yamashita, H Yagasaki, T Toda, M Yabe, S Kato, S Asano, T Nakahata.   

Abstract

Fanconi anemia (FA) is an autosomal recessive disease characterized by congenital anomalies, aplastic anemia, and a susceptibility to leukemia. There are at least 8 complementation groups (A through H). Extensive analyses of the FA group C gene FANCC in Western countries revealed that 10% to 15% of FA patients have mutations of this gene. The most common mutation is IVS4 + 4 A to T (IVS4), a splice mutation in intron 4, which has been found only in patients of Ashkenazi Jewish ancestry. When we screened 29 Japanese patients (20 unrelated patients and 4 families) using polymerase chain reaction-single strand conformation polymorphism, we found 8 unrelated patients homozygous for IVS4. This is apparently the first non-Ashkenazi-Jewish population for whom this mutation has been detected. The Ashkenazi Jewish patients homozygous for IVS4 have a severe phenotype, in comparison with other FA patients. Our analyses of Japanese patients indicate no significant difference between IVS4 homozygotes and other patients with regard to severity of a clinical phenotype. Thus, ethnic background may have a significant effect on a clinical phenotype in FA patients carrying the same mutation. (Blood. 2000;95:1493-1498)

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10666230

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  13 in total

1.  Mutations in Fanconi anemia genes and the risk of esophageal cancer.

Authors:  Mohammad R Akbari; Reza Malekzadeh; Pierre Lepage; David Roquis; Ali R Sadjadi; Karim Aghcheli; Abbas Yazdanbod; Ramin Shakeri; Jafar Bashiri; Masoud Sotoudeh; Akram Pourshams; Parviz Ghadirian; Steven A Narod
Journal:  Hum Genet       Date:  2011-01-30       Impact factor: 4.132

Review 2.  Fanconi anaemia.

Authors:  M D Tischkowitz; S V Hodgson
Journal:  J Med Genet       Date:  2003-01       Impact factor: 6.318

3.  FANCD2 monoubiquitination and activation by hexavalent chromium [Cr(VI)] exposure: activation is not required for repair of Cr(VI)-induced DSBs.

Authors:  Susan K Vilcheck; Susan Ceryak; Travis J O'Brien; Steven R Patierno
Journal:  Mutat Res       Date:  2006-08-08       Impact factor: 2.433

Review 4.  Genetic counseling for Fanconi anemia: crosslinking disciplines.

Authors:  Heather A Zierhut; Rebecca Tryon; Erica M Sanborn
Journal:  J Genet Couns       Date:  2014-09-20       Impact factor: 2.537

5.  Correct mRNA processing at a mutant TT splice donor in FANCC ameliorates the clinical phenotype in patients and is enhanced by delivery of suppressor U1 snRNAs.

Authors:  Linda Hartmann; Kornelia Neveling; Stephanie Borkens; Hildegard Schneider; Marcel Freund; Elke Grassman; Stephan Theiss; Angela Wawer; Stefan Burdach; Arleen D Auerbach; Detlev Schindler; Helmut Hanenberg; Heiner Schaal
Journal:  Am J Hum Genet       Date:  2010-10-08       Impact factor: 11.025

Review 6.  Current knowledge on the pathophysiology of Fanconi anemia: from genes to phenotypes.

Authors:  T Yamashita; T Nakahata
Journal:  Int J Hematol       Date:  2001-07       Impact factor: 2.490

Review 7.  Fanconi anaemia and cancer: an intricate relationship.

Authors:  Grzegorz Nalepa; D Wade Clapp
Journal:  Nat Rev Cancer       Date:  2018-01-29       Impact factor: 60.716

8.  In vitro effect of fludarabine, cyclophosphamide, and cytosine arabinoside on chromosome breakage in Fanconi anemia patients: relevance to stem cell transplantation.

Authors:  Miharu Yabe; Hiromasa Yabe; Satoshi Hamanoue; Hiroyasu Inoue; Masae Matsumoto; Takashi Koike; Hiroyuki Ishiguro; Tsuyoshi Morimoto; Satoshi Arakawa; Toshio Ohshima; Atsuko Masukawa; Hayato Miyachi; Takayuki Yamashita; Shunichi Katob
Journal:  Int J Hematol       Date:  2007-05       Impact factor: 2.490

Review 9.  The concept and practice of Fanconi Anemia: from the clinical bedside to the laboratory bench.

Authors:  Zhan-He Wu
Journal:  Transl Pediatr       Date:  2013-07

10.  A Dutch Fanconi Anemia FANCC Founder Mutation in Canadian Manitoba Mennonites.

Authors:  Yne de Vries; Nikki Lwiwski; Marieke Levitus; Bertus Kuyt; Sara J Israels; Fré Arwert; Michel Zwaan; Cheryl R Greenberg; Blanche P Alter; Hans Joenje; Hanne Meijers-Heijboer
Journal:  Anemia       Date:  2012-06-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.